Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cells

International Journal of Oncology

Volumn 13, Issue 4, 1998, Pages 791-799

  Joshi, S S ^a   Babushkina Patz, N N ^a   Verbik, D J ^a   Gross, T G ^a   Tarantolo, S R ^a   Kuszynski, C A ^a   Pirruccello, S J ^a   Bishop, M R ^a   Kessinger, A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Antitumor activity; Bone marrow cells; Peripheral blood; Umbilical cord blood

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; STEM CELL FACTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CYTOTOXICITY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 0031669784     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.4.791     Document Type: Article

References (22)

1. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE and Gluckman E: Allogeneic sibling umbilical cord blood transplantation in children with malignant and nonmalignant disease. Lancet 346:214-219, 1995.
2. Pahwa RN, Fleischer A, Than S and Good RA: Successful hematopoietic reconstitution with transplantation of erythrocyte-depleted allogeneic human umbilical cord blood cells in a child with leukemia. Proc Natl Acad Sci USA 91:4485-4488, 1994.
3. Kurtzberg JK, Langhlin M, Graham ML, Smith C, Olson JF and Rubenstein P: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335:157-166, 1996.
4. Leary AG and Ogawa M: Blast cell colony assay for umbilical cord blood and adult bone marrow progenitors. Blood 69:953-956, 1987.
5. Cairo MS and Wagner JE: Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 90:4665-4678, 1997.
6. Gardiner CM, O'Meara A and Reen DJ: Differential cytotoxicity of cord blood and bone marrow-derived natural killer cells. Blood 91:207-213, 1998.
7. Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Cooper S, English D, Kurtberg J, Bard J and Boyse EA: Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:1174-1178, 1989.
8. Apperley JF: Umbilical cord blood progenitor cell transplantation. Bone Marrow Transplant 14:187-196, 1994.
9. Harris DT, Lo Cascia J and Besencon FJ: Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease. Bone Marrow Transplant 14:545-553, 1994.
10. Harris DT: In vitro and in vivo assessment of the graft-versusleukemia activity of cord blood. Bone Marrow Transplant 15: 17-23, 1995.
11. Joshi SS, Wu AG, Verbik DJ, Algarra SM, Bishop MR, Pirruccello SJ, Iversen PL, Jackson JD, Kessinger A and Sharp JG: Oligonucleotides complementary to c-myb messenger RNA inhibit growth and induce apoptosis in human Burkitt lymphoma cells. Int J Oncol 8:815-820, 1996.
12. Joshi SS, Connors SJ, Weisenburger DD, Sharp JG, Gharpure HM and Brunson KW: Enhanced antiproliferative activity by metastatic RAW117 lymphoma cells. Clin Exp Metastasis 9: 27-37, 1991.
13. Verbik DJ, Jackson JD, Pirruccello SJ, Patil KD, Kessinger A and Joshi SS: Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections. Blood 85:1964-1970, 1995.
14. Pross F, Baines M, Rubin P, Shragge P and Patterson M: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol 1:51-63, 1981.
15. Beck R and Lam-Po-Tang PRL: Comparison of cord blood and adult blood lymphocyte normal ranges: a possible explanation for decreased severity of graft versus host disease after cord blood transplantation. Immun Cell Biol 72:440-444, 1994.
16. Keever CA: Characterization of cord blood lymphocyte subpopulations. J Hematother 2:203, 1993.
17. Keever CA, Abu-Hajir M, Graf W, McFadden P, Prichard P, O'Brien J and Flomenberg N: Characterization of the alloreactive and anti-leukemia reactivity of cord blood mononuclear cells. Bone Marrow Transplantant 15:407-419, 1995.
18. Kakutani FM, Martin M, Petrie HT and Boyd AW: A novel population of natural killer progenitor cells isolated from human umbilical cord blood. J Immunol 151:29-37, 1993.
19. Montagna D, Moretta A, Marconi M, Mingrat G, Gasparoni A, Giarola M and Maccario R: In vivo activated cord blood lymphocytes express high affinity interleukin-2 receptor: evaluation of their responsiveness to in vitro stimulation with recombinant interleukin-2. Biol Neonate 62: 385-394, 1992.
20. Harris DT, Schumacher J, Locascio J, Besencon F, Olson GB, De Luca D, Shenker L, Bard J and Boyse EA: Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA 89:10006-10010, 1992.
21. Vujanovic NL, Herberman RB, Maghazachi AA and Hiserodt J: Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells. J Exp Med 167:15-29, 1988.
22. Hiserodt JC: Lymphokine-activated killer cells: biology and relevance to disease. Cancer Invest 11:420-439, 1993.